By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MorphoSys AG 

Lena-Christ-Strasse 48

Martinsried  Munich  82152  Germany
Phone: 49-0-89-899-27-0 Fax: 49-0-89-899-27-222



Company News
MorphoSys AG To Host Q1 2017 Conference Call On May 3, 2017 4/24/2017 11:10:02 AM
MorphoSys AG Release: How To Maintain Equal Focus On Drug Safety, Efficacy, Patient Recruitment And Monitoring 4/11/2017 2:29:41 PM
MorphoSys AG Nominates New Candidate for Supervisory Board 4/3/2017 12:44:51 PM
MorphoSys AG's CSO Marlies Sproll Takes Temporary Leave 3/23/2017 9:45:04 AM
MorphoSys AG Announces That Its Licensee Janssen R&D Has Reported New Data From Two Phase III Studies Of Guselkumab In Plaque Psoriasis 3/3/2017 7:47:47 AM
Invitation To Year-End Results 2016 Conference Call Of MorphoSys AG On March 9, 2017 3/2/2017 9:33:01 AM
MorphoSys AG's Subsidiary Lanthio Pharma Initiates First-in-Human Clinical Study With Lanthipeptide MOR107 2/21/2017 9:01:34 AM
MorphoSys AG Release: Company Partner To Start Phase 2 Trial With Bimagrumab In Obese Patients With Type 2 Diabetes 1/12/2017 9:45:16 AM
Dr. Malte Peters To Become New Chief Development Officer Of MorphoSys AG 1/5/2017 9:56:06 AM
MorphoSys AG To Present At Upcoming Investor Conferences 1/3/2017 8:46:41 AM